Skip to main content

Invesco Ltd.

SEC CIK
0000914208
Latest filing
Aug 14, 2026

ANTX holding history

AN2 Therapeutics, Inc. in every 13F filed by Invesco Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ANTX overviewAll 13F holders of ANTXFull Q2 2026 holdings

Shares (Q2 2026)
13,839
Value
$67.0K
% of portfolio
<0.1%
Quarters held
3
Since Q3 2023
Holdings of ANTX by Invesco Ltd., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202613,839$67.0K<0.1%+13,839NewHolders
Q1 20240$00.0%−157,891−100.0%Sold outHolders
Q4 2023157,891$3.24M<0.1%−30,006−16.0%ReducedHolders
Q3 2023187,897$3.02M<0.1%+187,897NewHolders